The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Adenovirus-Mediated Overexpression of Tissue Inhibitor of Metalloproteinase-1 Reduces Atherosclerotic Lesions in Apolipoprotein E–Deficient Mice
Open accessAbstract
Background —To define the role of metalloproteinases (MMPs) in the development of lipid-rich atherosclerotic lesions in relation to the balance between proteolytic and antiproteolytic activities, we investigated the impact of adenovirus-mediated elevation in the circulating levels of human tissue inhibitor of MMP (TIMP-1) in atherosclerosis-susceptible apolipoprotein E–deficient (apoE −/− ) mice. Methods and Results —Infusion of apoE −/− mice fed a lipid-rich diet with rAd.RSV.TIMP-1 (1×10 11 viral particles) resulted in high hepatic expression of TIMP-1. At 2 weeks after injection, plasma TIMP-1 levels ranged from 7 to 24 μg/mL (mean 14.8±6.8). Marked overexpression of TIMP-1 was transient, with levels of TIMP-1 decreasing to 2.5 to 8 μg/mL (mean 4.3±2.1) at 4 weeks. Plasma lipid and lipoprotein levels in mice treated with rAd.RSV.TIMP-1 were similar to those treated with rAd.RSV.βGal. However, rAd.RSV.TIMP-1–infused mice displayed a marked reduction (≈32%; P <0.05) in mean lesion area per section (512±121 μm 2 ×10 3 ; n=12 sections from 4 animals) as compared with rAd.RSV.βGal-infused mice (750±182 μm 2 ×10 3 ; n=12 sections from 4 animals). Similarly, marked reduction in macrophage deposition as well as MMP-2, MMP-3, and MMP-13 antigens was observed. Conclusions —Histological and immunohistologic analyses of atherosclerotic lesions revealed increases in collagen, elastin, and smooth muscle α-actin content in mice treated with rAd.RSV.TIMP-1. These qualitative and quantitative features were the consequence of TIMP-1 infiltration from plasma to arterial intima, as immunohistochemical analyses revealed an abundance of TIMP-1 specifically in lesions of rAd.RSV.TIMP-1–treated mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Davies, M. J., & Thomas, A. C. (1985) · Heart · doi:10.1136/hrt.53.4.363 · Cited by 1,985
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.133 · Cited by 1,693
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
Sakalihasan, N., Limet, R., & Defawe, O. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66459-8 · Cited by 1,152
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease
Wang, X., & Khalil, R. A. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.08.002 · Cited by 754
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
Raffetto, J. D., & Khalil, R. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.004 · Cited by 752
NEWBY, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.08.002 · Cited by 529
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice
Sukhova, G. K., Zhang, Y., Pan, J.-H., Wada, Y., Yamamoto, T., Naito, M., Kodama, T., Tsimikas, S., Witztum, J. L., Lu, M. L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14915 · Cited by 372
Johnson, J. L., George, S. J., Newby, A. C., & Jackson, C. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506201102 · Cited by 352
The Role of Matrix Metalloproteinases in Wound Healing
Armstrong, D. G., & Jude, E. B. (2002) · Journal of the American Podiatric Medical Association · doi:10.7547/87507315-92-1-12 · Cited by 350
Apoptosis in the vasculature: mechanisms and functional importance
Mallat, Z., & Tedgui, A. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703407 · Cited by 343
Luttun, A., Lutgens, E., Manderveld, A., Maris, K., Collen, D., Carmeliet, P., & Moons, L. (2004) · Circulation · doi:10.1161/01.cir.0000121728.14930.de · Cited by 308
Matrix metalloproteinases A review of their structure and role in acute coronary syndrome
Jones, C. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00516-9 · Cited by 307
Manning, M. W., Cassis, L. A., & Daugherty, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058404.92759.32 · Cited by 303
Metalloproteinases and Vulnerable Atherosclerotic Plaques
Newby, A. C. (2007) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2007.09.001 · Cited by 253
Hansson, J., Vasan, R. S., Ärnlöv, J., Ingelsson, E., Lind, L., Larsson, A., Michaëlsson, K., & Sundström, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016185 · Cited by 103
“The investigated proteins may be causally involved in atherosclerosis development. In experimental settings, increased TIMP-1 expression has led to decreased atherosclerosis development in some”
BackgroundJohnson, J. L., Sala-Newby, G. B., Ismail, Y., Aguilera, C. M., & Newby, A. C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.170548 · Cited by 68
Metadata
- Authors
- Rouis, M., Adamy, C., Duverger, N., Lesnik, P., Horellou, P., Moreau, M., Emmanuel, F., Caillaud, J. M., Laplaud, P. M., Dachet, C., & Chapman, M. J.
- Venue
- Circulation
- Published
- 1999-08-03
- Volume
- 100
- Issue
- 5
- Pages
- 533-540
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2127557759
- Cited by
- 165
- References
- 5
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.